Table 2.
Comparison of PRKCI polymorphism in HCC patients and control with respect to gender.
| Genotype | Frequency distribution | Odds ratio | Relative risk | P value | |||
|---|---|---|---|---|---|---|---|
| Patients % | Control % | Value | 95% CI | Value | 95% CI | ||
| GG (F) | 26.00 | 40.74 | 0.5111 | 0.2130 to 1.223 | 0.6927 | 0.4145 to 1.082 | 0.1466 |
| TT (F) | 64.00 | 31.48 | 3.869 | 1.701 to 8.831 | 1.995 | 1.319 to 3.116 | 0.0015 |
| GT (F) | 10.00 | 27.78 | 0.2889 | 0.1088 to 0.8573 | 0.4667 | 0.2046 to 0.9125 | 0.0260 |
| GG (M) | 20.00 | 30.43 | 0.5714 | 0.2282 to 1.398 | 0.7500 | 0.4262 to 1.182 | 0.2505 |
| TT (M) | 66.00 | 30.43 | 4.437 | 1.802 to 10.01 | 2.024 | 1.350 to 3.164 | 0.0006 |
| GT (M) | 14.00 | 39.13 | 0.2532 | 0.1011 to 0.6524 | 0.4623 | 0.2307 to 0.8207 | 0.0058 |